Aquestive Therapeutics Inc — Balance Sheet (NASDAQ:AQST) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Total assets 62.88 M61.99 M57.07 M57.42 M101.42 M Total liabilities 111.38 M144.13 M175.62 M163.91 M161.58 M Total equity 48.5 M82.13 M118.55 M106.49 M60.16 M Total liabilities & shareholders' equities 62.88 M61.99 M57.07 M57.42 M101.42 M Total debt ————— Net debt —————

뉴스

Aquestive Therapeutics、OppenheimerカンファレンスでAnaphylmの戦略的見解を示す

Aquestive Therapeutics at Oppenheimer Conference: Strategic Insights on Anaphylm

アクエスティブ、アレルギー専門家のグリーンホート博士を最高医療責任者に任命

Aquestive appoints allergy expert Dr. Greenhawt as chief medical officer

H.C. ワインライト、FDAの回答後もAquesstive株の「買い」評価を維持

H.C. Wainwright reiterates Buy rating on Aquestive stock after FDA response

Aquestive Therapeutics, Inc. (AQST) Discusses FDA Complete Response Letter and Next Steps for Anaphylm Epinephrine Sublingual Film - Slideshow (NASDAQ:AQST) 2026-02-03

リードアレルギー治療薬のFDA更新後、アクエスティブ・セラピューティクス株の動向はどうなっていますか？

Disney, Micron Tech among market cap stock movers on Monday

Aquestive Therapeutics, Inc. (AQST) Discusses FDA Complete Response Letter and Next Steps for Anaphylm Epinephrine Sublingual Film Transcript

What's Going On With Aquestive Therapeutics Stock Today? - Aquestive Therapeutics (NASDAQ:AQST)

アクエスティブ社、アナフィルム承認見送りにも関わらず株価上昇